These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2439920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
    Etlinger HM, Felix AM, Gillessen D, Heimer EP, Just M, Pink JR, Sinigaglia F, Stürchler D, Takacs B, Trzeciak A.
    J Immunol; 1988 Jan 15; 140(2):626-33. PubMed ID: 3275719
    [Abstract] [Full Text] [Related]

  • 4. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
    Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Krzych U, Marchand M.
    N Engl J Med; 1997 Jan 09; 336(2):86-91. PubMed ID: 8988885
    [Abstract] [Full Text] [Related]

  • 5. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
    Polhemus ME, Magill AJ, Cummings JF, Kester KE, Ockenhouse CF, Lanar DE, Dutta S, Barbosa A, Soisson L, Diggs CL, Robinson SA, Haynes JD, Stewart VA, Ware LA, Brando C, Krzych U, Bowden RA, Cohen JD, Dubois MC, Ofori-Anyinam O, De-Kock E, Ballou WR, Heppner DG.
    Vaccine; 2007 May 22; 25(21):4203-12. PubMed ID: 17442466
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide.
    Pessi A, Valmori D, Migliorini P, Tougne C, Bianchi E, Lambert PH, Corradin G, Del Giudice G.
    Eur J Immunol; 1991 Sep 22; 21(9):2273-6. PubMed ID: 1889465
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of 5.1-[NANP]19, a recombinant Plasmodium falciparum vaccine candidate, in adults.
    Stürchler D, Just M, Berger R, Reber-Liske R, Matile H, Etlinger H, Takacs B, Rudin C, Fernex M.
    Trop Geogr Med; 1992 Jan 22; 44(1-2):9-14. PubMed ID: 1496731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Vaccination against malaria: initial trial with an ant-sporozoite vaccine, (NANP)3-TT (RO 40-2361) in Africa (Bobo-Dioulasso, Burkina Faso)].
    Guiguemdé TR, Sturchler D, Ouédraogo JB, Drabo M, Etlinger H, Douchet C, Gbary AR, Haller L, Kambou S, Fernex M.
    Bull Soc Pathol Exot; 1990 Jan 22; 83(2):217-27. PubMed ID: 2119897
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.
    Del Giudice G, Biro S, Degrémont AA, Engers HD, Lambert PH, Pessi A, Tougne C, Verdini AS, Weiss N, Tanner M.
    Parassitologia; 1986 Jan 22; 28(2-3):107-11. PubMed ID: 3332303
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H.
    Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of ELISAs employing repetitive peptides to detect antibodies to Plasmodium falciparum sporozoites.
    Del Giudice G, Douglas A, Verhave JP, Wirtz RA, Zavala F.
    Bull World Health Organ; 1989 Jul 09; 67(5):515-23. PubMed ID: 2692868
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.
    Quakyi IA, Otoo LN, Pombo D, Sugars LY, Menon A, De Groot AS, Johnson A, Alling D, Miller LH, Good MF.
    Am J Trop Med Hyg; 1989 Aug 09; 41(2):125-34. PubMed ID: 2672834
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.